This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_MELANOMA_EXALLC for full statistics.
Melanoma in situ
CD2_INSITU_MELANOMA
melanoma: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1355 |
4. Check minimum number of eventsNone |
1355 |
5. Include endpoints |
1355 |
6. Filter based on genotype QC (FinnGen only) |
1355 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D00-D09
- Name in latin
- Melanoma in situ
Similar endpoints
↥List of similar endpoints to
Melanoma in situ
based on the number of shared cases.
Similar with more cases:
- Melanoma in situ
- Malignant melanoma
- Malignant melanoma, excluding all cancers (controls excluding all cancers)
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1355 | 685 | 670 |
| Unadjusted period prevalence (%) | 0.26 | 0.23 | 0.30 |
| Median age at first event (years) | 69.12 | 66.85 | 71.44 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1179
- Matched controls
- 11788
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D03.5
ICD-10 Finland
Melanoma in situ of trunk
2883.6
323.0
374
*
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
3872.3
323.0
305
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
17.3
280.1
482
452
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
11.8
236.6
497
684
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
+∞
204.2
190
*
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
450.3
196.2
191
5
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
9.2
188.4
454
750
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
+∞
185.4
173
*
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
13.4
151.1
280
268
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
18.7
140.2
223
145
L57.0
ICD-10 Finland
Actinic keratosis
6.8
137.7
408
855
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
17.0
128.6
212
150
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
13.5
124.2
227
205
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
8.9
124.1
289
415
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
+∞
97.2
92
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
4.5
93.3
400
1198
S18
ICPC
Laceration/cut
3.4
87.3
740
3876
ZZR00
NOMESCO Finland
Flap of skin
13.3
86.4
157
135
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
+∞
84.4
80
*
TQW99
NOMESCO Finland
Other minor procedure on skin
7.4
80.9
208
332
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
31.7
80.2
107
37
D03.4
ICD-10 Finland
Melanoma in situ of scalp and neck
+∞
74.8
71
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
5.5
71.2
233
505
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
16.7
63.3
103
67
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
27.5
63.1
87
34
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
7.8
54.8
132
187
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
10.1
51.2
105
113
L82
ICD-10 Finland
Seborrhoeic keratosis
3.1
49.1
321
1257
SPAT1153
SPAT
Removal of sutures
2.6
48.6
543
2954
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
18.1
47.8
75
44
S82
ICPC
Naevus/mole
3.4
44.3
245
841
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
6.7
44.0
117
190
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
18.8
42.8
66
37
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
116.8
42.0
45
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
21.4
41.3
61
30
D03.30
ICD-10 Finland
Melanoma in situ on the lip
+∞
39.8
38
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
20.9
37.7
56
28
D06BB10
ATC
imiquimod; topical
5.0
37.6
129
285
C43
ICD-10 Finland
Malignant melanoma of skin
35.7
37.4
48
14
ZXC50
NOMESCO Finland
Cryotherapy
5.6
36.6
111
213
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
62.1
36.4
42
7
S77
ICPC
Malignant neoplasm of skin
11.6
36.1
68
62
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
7.5
35.8
87
124
D22
ICD-10 Finland
Melanocytic naevi
6.3
34.9
96
163
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
43.4
34.2
42
10
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
3.7
34.1
161
481
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
39.5
33.6
42
11
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
13.5
32.7
57
44
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
18.6
32.5
50
28
D03.2
ICD-10 Finland
Melanoma in situ of ear and external auricular canal
+∞
32.4
31
*
PJA12
NOMESCO Finland
Sentinel node biopsy
3.5
30.7
155
488
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
7.4
28.5
69
98
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
5.6
25.9
78
148
ZXC20
NOMESCO Finland
Use of chemical agents
5.9
25.1
72
129
ZZA00
NOMESCO Finland
Split skin graft
4.8
24.3
83
182
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
5.9
23.7
68
122
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
4.0
22.8
96
258
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
7.0
22.8
57
85
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
5.4
22.7
69
133
WX110
NOMESCO Finland
Local anesthesy
1.9
22.4
777
6000
S29
ICPC
Skin symptom/complaint other
2.2
22.0
255
1303
D03.1
ICD-10 Finland
Melanoma in situ of eyelid, including canthus
+∞
21.9
21
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
29.7
21.9
29
10
C43.51
ICD-10 Finland
Malignant melanoma of the trunk originating in lentigo maligna
25.6
21.8
30
12
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
12.6
21.4
38
31
8720/2-C44.5
ICD-O-3
Melanoma in situ of skin of trunk
213.5
20.6
21
*
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
9.4
20.4
42
46
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
6.1
20.0
55
94
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
36.4
19.9
25
7
XQ848
NOMESCO Finland
Dermatological photography
4.8
19.7
67
147
D03.8
ICD-10 Finland
Melanoma in situ of other sites
203.2
19.6
20
*
A98
ICPC
Health maint/preventive medicine
2.9
19.6
1114
10102
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
10.9
19.0
36
34
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
9.8
18.9
38
40
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
5.8
18.9
54
97
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
24.1
18.7
26
11
XQ845
NOMESCO Finland
Dermatoscopy
6.8
18.3
46
70
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
25.5
18.3
25
10
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
22.1
18.2
26
12
ZZA50
NOMESCO Finland
Full thickness skin graft
10.6
17.2
33
32
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
16.2
17.1
27
17
ZXC15
NOMESCO Finland
Use of photodynamic technique
5.9
16.9
47
82
ZQZ00
NOMESCO Finland
Treatment of several skin areas
9.9
16.7
33
34
I78.1
ICD-10 Finland
Naevus, non-neoplastic
4.8
16.6
55
118
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
28.0
16.5
22
8
C43.30
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face without histology
20.4
16.5
24
12
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
11.9
16.1
29
25
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
18.8
16.0
24
13
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
6.8
15.6
39
59
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
38.6
15.4
19
5
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
5.4
15.4
46
88
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
5.9
15.2
42
73
S21
ICPC
Skin texture symptom/complaint
2.1
15.0
178
908
D03.0
ICD-10 Finland
Melanoma in situ of lip
+∞
14.6
14
*
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
14.4
14.6
24
17
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
5.6
14.3
41
75
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
8.8
14.3
30
35
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
3.9
13.9
57
151
8720/3-C44.3
ICD-O-3
Malignant melanoma, NOS, of skin of other and unspecified parts of face
30.4
13.9
18
6
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
5.4
13.8
41
78
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
5.6
13.7
39
71
C43.42
ICD-10 Finland
Malignant melanoma of the scalp and neck: 'superficial spreading' type
76.0
13.6
15
*
DHB00
NOMESCO Finland
Excision of lesion of external nose
6.3
13.4
35
57
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
7.7
13.2
30
40
S26
ICPC
Fear of cancer of skin
6.3
13.1
34
55
C43.71
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip originating in lentigo maligna
50.6
12.9
15
*
D03
ICD-10 Finland
Melanoma in situ
131.3
12.5
13
*
J01DB01
ATC
cefalexin; oral
1.7
12.3
921
8032
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.7
12.3
84
324
DAB10
NOMESCO Finland
Partial excision of auricle
10.6
12.3
23
22
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.6
11.9
85
336
8743/3-C44.5
ICD-O-3
Low cumulative sun damage melanoma of skin of trunk
47.1
11.9
14
*
E0000UV
ATC
NA
1.6
11.8
437
3198
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
65.6
11.6
13
*
WX002
NOMESCO Finland
Sedation and analgesia
1.7
11.6
261
1667
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
9.4
11.5
23
25
C43.32
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face 'superficial spreading' type
35.4
11.3
14
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
17.2
11.2
17
10
8742/3-C44.9
ICD-O-3
Lentigo maligna melanoma of skin, NOS
25.3
11.1
15
6
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
11.1
270
1759
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
3.1
10.8
58
193
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
3.8
10.6
44
120
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
9.3
10.5
21
23
8720/2-C44.6
ICD-O-3
Melanoma in situ of skin of upper limb and shoulder
110.9
10.4
11
*
8720/2-C44.7
ICD-O-3
Melanoma in situ of skin of lower limb and hip
+∞
10.4
10
*
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
2.6
10.2
73
291
DAB00
NOMESCO Finland
Excision of lesion of auricle
5.0
10.1
31
63
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
9.2
10.0
20
22
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
10.1
10.0
19
19
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
4.2
10.0
37
91
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
9.9
187
1128
S79
ICPC
Neoplasm skin benign/unspecified
4.4
9.7
34
79
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.1
9.7
106
519
C43.9
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of skin, unspecified
21.9
9.4
13
6
C43.73
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip nodular
21.9
9.4
13
6
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
9.2
361
2645
180
Kela drug reimbursment
Interferon alfa
11.6
9.1
16
14
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
11.6
9.1
16
14
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
9.1
9.0
18
20
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
9.0
317
2259
N02BE01
ATC
paracetamol; systemic, rectal
1.6
9.0
987
8965
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
7.5
8.9
20
27
TQW80
NOMESCO Finland
Local dermatologic skincare
3.2
8.8
44
140
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
8.6
173
1058
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
8.3
8.6
18
22
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
8.3
8.6
18
22
S08
ICPC
Skin colour change
2.5
8.6
68
287
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
9.1
8.5
17
19
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
8.4
531
4268
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
8.4
481
3795
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
4.5
8.4
28
63
TQW40
NOMESCO Finland
Remowal of suture of skin
2.1
8.3
90
441
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
6.1
8.2
21
35
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
6.9
8.1
19
28
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
3.2
8.0
39
123
D06BX02
ATC
ingenol mebutate; topical
3.7
7.9
33
92
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
4.2
7.8
28
68
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
9.5
7.8
15
16
8742/3-C44.3
ICD-O-3
Lentigo maligna melanoma of skin of other and unspecified parts of face
45.3
7.7
9
*
C43.91
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin originating in lentigo maligna
45.3
7.7
9
*
QCE99
NOMESCO Finland
Other excision or repair of lesion of skin of upper limb
7.5
7.7
17
23
C43.40
ICD-10 Finland
Malignant melanoma of the scalp and neck without histology
25.2
7.6
10
*
C44.3
ICD-10 Finland
Malignant neoplasm: Skin of other and unspecified parts of face
8.9
7.5
15
17
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
10.1
7.5
14
14
S15
ICPC
Foreign body in skin
2.1
7.5
79
382
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
7.4
282
2034
TQW40
SPAT
NA
2.9
7.4
43
153
8742/2-C44.5
ICD-O-3
Lentigo maligna of skin of trunk
+∞
7.3
7
*
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.0
7.1
93
493
R4110
NOMESCO Finland
Physiotherapy
1.5
7.0
296
2176
M01AH05
ATC
etoricoxib; oral
1.4
6.9
590
4950
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
7.6
6.9
15
20
J01CA04
ATC
amoxicillin; systemic
1.4
6.9
841
7510
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
6.7
6.8
16
24
C43.61
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna
22.6
6.7
9
*
ZXA00
NOMESCO Finland
Right side
1.4
6.7
318
2399
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
4.5
6.7
22
50
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
6.6
251
1805
WW200
SPAT
NA
0.4
6.6
23
588
C44
ICD-10 Finland
Other malignant neoplasms of skin
8.7
6.6
13
15
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.1
6.5
68
331
ZXA05
NOMESCO Finland
Left side
1.5
6.5
293
2183
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
6.5
427
3415
Z31.5
ICD-10 Finland
Genetic counselling
2.6
6.4
43
168
C43.20
ICD-10 Finland
Malignant melanoma of the outer ear and in the external ear canal without histology
70.2
6.4
7
*
8742/2-C44.3
ICD-O-3
Lentigo maligna of skin of other and unspecified parts of face
70.2
6.4
7
*
D22.2
ICD-10 Finland
Melanocytic naevi of ear and external auricular canal
14.4
6.4
10
7
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
14.4
6.4
10
7
WX320
NOMESCO Finland
Spinalanesthesy
1.5
6.4
261
1906
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.5
6.3
232
1656
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
6.0
6.3
16
27
QAA25
SPAT
NA
18.1
6.3
9
5
C43.82
ICD-10 Finland
Overall malignant melanoma of the skin: 'superficial spreading' type
+∞
6.3
6
*
D02AE01
ATC
carbamide; topical
2.0
6.2
79
415
QDA50
NOMESCO Finland
Cryotherapy of skin of lower limb
26.8
6.2
8
*
C43.29
ICD-10 Finland
Malignant melanoma of the outer ear and in the external ear canal other or unspecified histology
26.8
6.2
8
*
UJF30
NOMESCO Finland
Ileoscopy through colon
1.8
6.2
103
597
D23.6
ICD-10 Finland
Benign neoplasm: Skin of upper limb, including shoulder
5.8
6.2
16
28
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
5.8
6.2
16
28
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
6.1
181
1232
ZXC12
NOMESCO Finland
Pulse colorlaser
10.1
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
678
1514
7.96
323.01
1.9
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1081
4582
7.72
241.06
4.4
2.2
—
—
—
0
0
(4035726)
343
1085
3.89
93.46
1.5
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
206
518
4.51
75.79
1.4
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1234
10528
2.93
29.73
19.5
15.8
ml/min/173m2
74.4
75.0
0.41
1057
8746
(42870588) Differential panel, method unspecified - Blood
565
3983
1.72
20.04
7.0
5.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1296
11769
3.32
19.99
13.2
11.3
u/l
24.4
25.0
0.66
1238
11291
(3010813) Leukocytes [#/volume] in Blood
1318
12126
4.18
19.18
27.8
24.6
e9/l
6.7
6.8
1.79
1281
11740
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
267
1523
1.94
19.03
5.4
4.0
u/l
242.3
251.5
0.37
253
1435
(3007461) Platelets [#/volume] in Blood
1317
12120
4.09
18.96
27.8
24.6
e9/l
243.6
243.4
0.04
1283
11778
(3024731) MCV [Entitic volume]
1317
12122
4.08
18.91
27.7
24.5
fl
91.6
91.6
0.10
1295
11912
(3035941) MCH [Entitic mass]
1317
12123
4.08
18.89
27.7
24.5
pg
30.4
30.4
0.14
1295
11911
(3026361) Erythrocytes [#/volume] in Blood
1317
12124
4.08
18.87
27.8
24.6
e12/l
4.4
4.4
1.70
1278
11743
(3000963) Hemoglobin [Mass/volume] in Blood
1317
12126
4.07
18.82
27.9
24.8
g/l
134.1
133.3
1.05
1295
11918
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1248
11181
2.47
18.65
5.7
5.3
mmol/l
2.6
2.6
0.02
1110
10098
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1241
11096
2.41
18.55
18.3
16.7
mg/l
22.3
26.0
3.61
1020
8988
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1226
10918
2.29
18.30
5.0
4.7
mmol/l
4.5
4.5
0.02
1094
9920
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1213
10819
2.16
16.99
5.1
4.7
mmol/l
1.5
1.5
1.22
1076
9745
(3033658) Prothrombin time (PT) actual/Normal
440
3014
1.68
16.63
4.4
4.0
%
85.7
86.1
0.12
427
2941
(3013115) Eosinophils [#/volume] in Blood
750
5886
1.61
16.29
7.3
5.9
e9/l
0.2
0.2
1.21
610
5127
(3006315) Basophils [#/volume] in Blood
730
5701
1.61
16.11
7.1
5.6
e9/l
0.0
0.0
0.11
591
4887
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
729
5695
1.61
16.03
6.5
6.1
mmol/l
1.2
1.2
2.28
654
5122
(3001604) Monocytes [#/volume] in Blood
727
5679
1.60
15.97
7.1
5.6
e9/l
0.6
0.6
0.10
586
4859
(3022096) Basophils/100 leukocytes in Blood
678
5219
1.60
15.76
7.5
5.9
%
0.7
0.7
0.32
612
4855
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1178
10460
1.97
15.73
4.5
4.2
mmol/l
1.3
1.3
0.15
1036
9345
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1220
10968
2.13
15.72
5.5
5.0
mmol/l
6.0
6.1
1.71
1074
9818
(3023103) Potassium [Moles/volume] in Serum or Plasma
1279
11725
2.62
15.72
22.3
19.9
mmol/l
4.0
4.0
2.84
1247
11408
(3019550) Sodium [Moles/volume] in Serum or Plasma
1275
11698
2.52
15.15
21.8
19.8
mmol/l
139.7
139.6
0.58
1244
11393
(3019198) Lymphocytes [#/volume] in Blood
735
5801
1.58
15.11
7.1
5.7
e9/l
1.8
1.9
1.08
603
5063
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1155
10229
1.87
14.98
5.7
4.8
mu/l
1.9
2.1
1.05
1023
9203
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1179
10524
1.93
14.73
6.6
6.5
mmol/mol
39.7
40.6
3.14
1055
9612
(3006504) Eosinophils/100 leukocytes in Blood
686
5370
1.56
14.31
7.4
5.9
%
2.7
2.8
0.56
619
4984
(3019069) Monocytes/100 leukocytes in Blood
688
5390
1.56
14.29
7.6
6.2
%
9.1
8.9
1.41
623
5027
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
773
6232
1.56
14.02
6.8
7.0
mmol/l
1.2
1.2
2.29
640
5245
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
379
2605
1.63
13.65
3.8
3.3
ug/l
0.8
0.8
0.36
271
1841
(3044640) Blood type and Crossmatch panel - Blood
519
3844
1.57
13.63
2.6
2.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
810
6633
1.55
13.43
10.0
9.2
e9/l
4.0
4.2
3.35
669
5794
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1046
9092
1.66
13.42
9.1
7.8
u/l
77.7
80.0
0.75
967
8515
(3021589) Normoblasts [#/volume] in Blood
647
5051
1.54
13.31
12.5
10.3
e9/l
0.0
0.0
0.15
505
4143
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
984
8447
1.60
13.05
4.5
3.9
pmol/l
15.1
15.0
0.51
844
7549
(3002030) Lymphocytes/100 leukocytes in Blood
691
5489
1.53
13.00
7.6
6.0
%
26.7
26.4
0.26
625
5084
(3018010) Neutrophils/100 leukocytes in Blood
681
5393
1.53
13.00
7.3
5.8
%
58.3
58.3
0.02
620
5026
(3031040) Bacteria [#/volume] in Urine by Automated count
926
7847
1.57
12.89
5.0
4.9
e6/l
2863.2
2234.0
0.08
17
130
(40761511) CBC panel - Blood by Automated count
1244
11417
2.09
12.77
17.0
16.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
567
4366
1.51
12.05
4.6
3.9
e6/l
93.0
124.4
0.49
412
3210
(3026493) Urate [Moles/volume] in Serum or Plasma
432
3144
1.55
11.90
2.9
2.9
umol/l
5185.1
7612.0
0.43
362
2663
(3009542) Hematocrit [Volume Fraction] of Blood
1092
9694
1.65
11.81
21.2
18.2
%
39.3
38.8
1.20
738
6185
(36304419) Bacteria [Presence] in Urine
454
3354
1.53
11.63
3.8
3.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
505
3820
1.51
11.56
3.9
3.4
e6/l
56.7
85.8
0.63
397
3005
(3019420) Tryptase [Mass/volume] in Serum or Plasma
27
60
4.57
11.45
2.2
1.5
ug/l
15.6
9.7
0.33
27
52
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
604
4759
1.49
11.23
2.3
2.2
nmol/l
83.4
78.7
3.82
517
4163
(3015377) Calcium [Moles/volume] in Serum or Plasma
552
4293
1.48
10.84
4.2
3.4
mmol/l
2.3
2.3
0.12
455
3688
(3035637) Corticotropin [Mass/volume] in Plasma
42
134
3.20
10.76
1.4
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
486
3692
1.49
10.69
5.4
4.1
ph
7.4
7.4
0.55
105
696
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
15
7
21.65
10.69
1.0
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
299
2044
1.59
10.66
3.4
3.1
e6/l
1.6
2.0
0.47
169
1159
(3013707) Erythrocyte sedimentation rate by Westergren method
977
8539
1.52
10.41
4.7
4.2
mm/h
12.6
13.8
1.45
884
7821
(3030467) Casts [#/volume] in Urine by Automated count
463
3513
1.48
10.12
3.9
3.3
e6/l
0.5
0.5
0.09
359
2707
(3037467) Urinalysis macro (dipstick) panel - Urine
924
8075
1.45
9.08
4.8
4.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
213
1396
1.62
8.92
1.4
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
561
4496
1.42
8.88
6.2
5.5
ug/l
5.0
3.2
0.48
475
3979
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
392
2951
1.46
8.66
2.5
2.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
228
1539
1.58
8.42
5.3
4.8
%
34.1
33.1
0.62
144
1008
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
643
5328
1.39
8.17
2.2
2.1
pmol/l
93.1
94.1
0.21
320
2766
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
745
6328
1.39
8.16
6.9
6.3
umol/l
11.1
11.9
1.66
697
5995
(3013512) EKG study
479
3787
1.41
7.96
4.1
4.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
652
5440
1.38
7.82
5.3
4.8
g/l
35.4
34.8
2.64
597
5055
(3022145) Colonoscopy Study observation
195
1297
1.59
7.64
1.4
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
669
5632
1.37
7.47
2.3
2.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
410
3190
1.41
7.36
1.6
1.6
nmol/l
21.4
20.2
0.79
327
2673
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
296
2171
1.47
7.32
3.3
2.9
e6/l
0.9
1.1
0.67
166
1281
(3002385) Erythrocyte distribution width [Ratio]
998
8988
1.42
7.26
24.6
20.4
%
13.8
13.9
0.52
980
8775
(40768795) Lymph node Pathology biopsy report
32
111
2.93
7.19
1.3
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
161
1040
1.62
7.11
3.7
3.6
ng/l
95.9
93.0
0.15
133
894
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
656
5537
1.36
7.05
4.2
4.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
784
6809
1.36
6.97
3.2
3.2
u/l
43.9
54.5
4.42
699
6225
(40758558) Short blood count panel - Blood
377
2919
1.40
6.88
7.4
6.9
—
—
—
0
0
(3026782) Osmolality of Urine
339
2577
1.42
6.87
3.1
2.9
mosm/kgh2o
575.6
551.2
1.43
291
2192
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
476
3835
1.37
6.82
2.2
2.2
u/l
210.2
230.3
0.18
441
3580
(3009214) Lutropin [Units/volume] in Serum or Plasma
43
179
2.45
6.82
1.1
1.2
u/l
11.6
11.4
0.03
35
137
(3020630) Protein [Mass/volume] in Serum or Plasma
171
1134
1.58
6.77
2.9
2.9
g/l
65.7
66.2
0.31
151
1028
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
388
3036
1.39
6.61
1.6
1.6
mmol/l
1.3
1.3
0.12
301
2493
(3036481) Cortisol [Moles/volume] in Serum or Plasma
157
1047
1.56
6.06
3.7
2.1
nmol/l
412.0
372.4
0.79
147
949
(3032080) INR in Blood by Coagulation assay
628
5352
1.32
5.96
11.1
10.8
inr
1.3
1.3
0.65
187
1481
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
83
470
1.82
5.93
3.0
2.8
g/l
1.2
1.5
0.24
64
407
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
78
438
1.83
5.73
2.2
2.6
g/l
37.1
37.2
0.02
62
376
(3000850) Epithelial cells [#/volume] in Urine
345
2705
1.37
5.69
3.0
2.6
e6/l
4.1
5.1
1.11
309
2386
(3036489) Thrombin time
73
403
1.86
5.66
2.8
1.9
s
22.0
21.8
0.12
68
368
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
323
2508
1.38
5.65
4.1
3.1
mmol/l
2.5
2.5
0.18
283
2203
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
74
411
1.85
5.63
2.3
2.7
g/l
0.0
0.0
0.52
61
376
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
192
1362
1.48
5.55
3.4
3.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
71
392
1.86
5.51
2.3
2.7
g/l
0.0
0.0
0.00
58
359
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
56
286
2.00
5.47
3.8
2.3
%
189.4
205.1
0.64
51
273
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
58
309
1.92
5.04
3.2
2.1
%
88.0
88.1
0.02
52
293
(40761536) Microorganisms panel - Urine sediment
147
1012
1.51
4.92
4.6
4.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
186
2513
0.70
4.88
4.3
4.4
kg/l
1.0
1.0
0.03
28
383
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
84
507
1.70
4.86
2.4
2.7
g/l
3.1
3.2
0.03
63
400
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
9
10
9.05
4.78
1.1
1.2
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
11
24
4.61
4.78
1.0
2.2
ug/l
1.3
2.0
—
5
11
(3013826) Glucose [Moles/volume] in Serum or Plasma
794
7112
1.28
4.71
4.9
4.9
mmol/l
6.6
6.8
3.47
760
6702
(3001122) Ferritin [Mass/volume] in Serum or Plasma
556
4767
1.28
4.68
3.2
2.8
ug/l
144.1
143.7
0.02
491
4313
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
84
513
1.68
4.66
2.1
2.7
g/l
10.7
10.6
0.10
67
435
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
150
1049
1.48
4.66
6.4
3.8
mmol/l
1.2
1.2
0.02
130
904
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
545
1.66
4.64
2.3
2.7
g/l
3.6
3.8
0.66
63
394
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
546
1.65
4.60
2.3
2.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
546
1.65
4.60
2.3
2.7
g/l
7.3
7.4
0.17
66
408
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
437
3641
1.30
4.58
4.7
4.8
%
21.6
21.7
0.04
229
1900
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
67
388
1.76
4.50
2.4
2.7
g/l
0.0
0.0
0.00
57
358
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
54
293
1.88
4.47
1.7
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
191
1409
1.41
4.47
1.7
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
55
305
1.84
4.27
1.3
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
20
487
0.40
4.24
2.3
3.9
mmol/l
1.9
1.4
0.81
20
477
(40768806) Pleura Pathology biopsy report
34
163
2.11
4.00
1.7
1.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
250
1963
1.34
3.97
2.5
2.0
s
30.5
29.9
0.89
242
1899
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
53
299
1.80
3.92
5.1
2.8
mg/l
1.9
1.8
0.40
48
269
(3019225) pH of Specimen
174
1297
1.39
3.84
4.2
4.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
43
229
1.91
3.81
1.1
1.3
iu/l
28.4
30.6
0.18
35
197
(3027945) Reticulocytes/100 erythrocytes in Blood
208
1602
1.35
3.75
2.8
2.5
%
1.8
1.8
0.49
177
1409
(3017446) Testosterone [Moles/volume] in Serum or Plasma
112
775
1.49
3.70
2.2
2.1
nmol/l
11.6
12.3
0.45
97
668
(3004588) Protein electrophoresis panel - Serum or Plasma
134
965
1.43
3.60
3.1
2.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
92
616
1.53
3.56
1.3
1.3
au/ml
95.9
51.8
—
5
25
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
60
365
1.67
3.45
1.6
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
48
275
1.77
3.41
1.3
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
122
873
1.44
3.40
1.8
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
451
3890
1.24
3.34
3.6
3.2
mmol/l
7.1
7.2
0.21
348
3209
(3044889) 12 lead EKG panel
891
8246
1.24
3.34
4.5
4.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
149
1110
1.38
3.31
2.3
2.3
u/l
30.7
34.1
0.81
127
932
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
175
1341
1.35
3.26
2.6
2.6
umol/l
7.0
9.1
1.06
149
1179
(3027273) Bicarbonate [Moles/volume] in Venous blood
39
681
0.56
3.25
3.6
3.2
mmol/l
25.5
25.3
0.15
39
661
(3023520) Reticulocytes [#/volume] in Blood
159
1202
1.37
3.23
2.9
2.6
e9/l
66.1
69.7
0.63
101
935
(3052851) Hemolysis interference index of Serum or Plasma
59
364
1.65
3.23
3.2
3.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
49
291
1.71
3.10
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
49
291
1.71
3.10
1.3
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
20
86
2.35
3.08
1.3
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
87
595
1.49
3.08
2.6
2.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
253
2060
1.28
3.05
3.1
3.1
mmol/l
0.8
0.8
0.06
227
1925
(3030905) Polymorphonuclear cells [#/volume] in Blood
40
226
1.79
3.01
3.4
3.1
e9/l
4.3
4.5
0.25
40
226
(1761868) Lipid panel - Serum or Plasma
394
3386
1.23
2.96
3.3
3.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
101
719
1.44
2.93
7.2
7.8
mmol/l
25.1
24.9
0.24
101
714
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
41
236
1.76
2.91
3.8
3.4
%
61.2
59.6
0.43
41
236
(3012516) Albumin [Mass/volume] in Urine
436
3797
1.22
2.87
3.7
3.3
mg/l
371.5
308.4
0.10
267
2419
(3011648) Oxygen content in Venous blood
21
98
2.16
2.71
2.6
1.7
%
10.0
11.1
0.51
21
98
(3003327) Ova and parasites identified in Stool by Light microscopy
49
305
1.63
2.65
1.7
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
84
591
1.45
2.62
3.3
3.3
pmol/l
4.2
4.4
1.42
73
517
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
75
518
1.47
2.57
3.7
3.6
u/ml
31.6
70.6
1.89
69
499
(40760892) CBC W Ordered Manual Differential panel - Blood
278
2334
1.24
2.57
5.2
4.6
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
5
7
7.17
2.55
5.2
5.9
—
—
—
0
0
(3020891) Body temperature
30
523
0.56
2.54
3.0
4.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
31
172
1.82
2.51
1.7
1.4
e6/l
101392.6
108756.5
0.04
17
100
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
83
588
1.44
2.50
1.8
1.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
85
605
1.43
2.50
3.8
3.7
mmol/l
24.5
24.0
0.85
79
542
(40768797) Stomach Pathology biopsy report
207
1686
1.27
2.49
1.4
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
22
109
2.04
2.47
1.0
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
26
137
1.92
2.46
1.2
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
12
45
2.68
2.45
1.3
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
51
2.56
2.44
1.5
1.3
—
—
—
0
0
(1002224) Polysomnography panel
50
320
1.58
2.44
1.0
1.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
39
627
0.61
2.43
4.0
3.8
%
47.9
47.4
0.05
39
619
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
12
5.02
2.40
3.8
4.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
136
1055
1.32
2.37
1.8
1.5
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
8
6.27
2.37
1.0
1.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
91
663
1.40
2.37
2.2
1.8
g/l
1.4
1.5
0.47
74
572
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
17
4.13
2.36
1.1
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
16
71
2.27
2.34
2.6
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
38
233
1.65
2.22
1.4
1.7
iu/l
3.8
4.9
—
10
75
(3012441) Differential panel - Pleural fluid
29
165
1.77
2.20
1.7
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
54
2.42
2.20
1.1
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
124
961
1.32
2.19
1.9
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
208
1722
1.25
2.18
7.9
5.4
mmol/l
1.0
1.0
0.33
195
1575
(3021601) Nitrite [Presence] in Urine by Test strip
615
5634
1.17
2.13
5.0
5.4
estimate
0.0
0.0
0.00
136
1093
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
174
1416
1.26
2.12
3.8
4.1
ug/l
4.1
22.8
2.40
140
1173
(3035350) Ketones [Presence] in Urine by Test strip
614
5626
1.17
2.12
3.7
4.0
estimate
0.0
0.0
0.00
132
1092
(3023199) Leukocytes [#/volume] in Pleural fluid
32
190
1.70
2.11
1.7
1.4
e6/l
1643.1
1719.1
0.05
20
132
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
290
2496
1.21
2.09
2.3
1.6
mg/l
1.9
1.4
0.38
220
1943
(3045142) Bone marrow Pathology biopsy report
27
153
1.78
2.09
1.1
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
153
1229
1.28
2.08
1.8
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
621
5701
1.16
2.08
3.7
4.0
estimate
0.0
0.0
0.80
135
1065
(3019060) Gas panel - Arterial blood
65
907
0.70
2.08
2.2
4.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
23
124
1.87
2.07
3.6
3.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
372
3278
1.19
2.07
2.3
2.2
mg/l
2.8
3.1
1.93
296
2773
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
211
1761
1.23
2.06
1.3
1.3
iu/ml
28.9
39.3
0.72
52
556
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
21
110
1.92
2.06
1.5
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
32
192
1.68
2.04
1.2
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
67
476
1.43
2.04
5.2
3.7
mg/l
57.2
65.7
0.22
53
394
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
14
63
2.23
2.01
1.8
1.5
g/l
0.9
1.0
0.52
14
63
(3020682) Albumin/Creatinine [Ratio] in Urine
450
4038
1.17
2.00
4.8
4.0
mg/mmol
7.4
9.3
0.62
263
2543
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
27
156
1.75
1.97
2.8
3.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
218
1835
1.22
1.97
1.9
2.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
31
187
1.67
1.95
1.6
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
64
2.20
1.94
1.1
1.5
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
11
4.56
1.94
1.8
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
66
473
1.42
1.93
1.5
2.0
u/l
36.2
38.7
0.38
57
415
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
400
3566
1.17
1.92
2.9
3.2
u/l
46.4
34.9
0.37
372
3386
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
259
2226
1.20
1.90
1.9
1.9
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
34
2.66
1.86
1.8
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
52
359
1.47
1.86
1.6
1.6
—
—
—
0
0
(3000492) Spirometry study
119
941
1.29
1.85
1.7
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
66
477
1.40
1.85
5.2
3.7
mg/l
52.3
82.6
0.51
52
397
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
128
1022
1.28
1.85
1.6
1.7
%
1.6
1.6
0.12
105
853
(3024928) Oxygen saturation in Venous blood
42
280
1.52
1.78
2.7
2.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
46
314
1.48
1.75
1.5
1.7
e6/l
7241.5
15578.8
1.46
23
230
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
36
233
1.56
1.74
1.5
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
24
2.93
1.72
5.6
4.5
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
5
13
3.86
1.71
1.0
1.2
—
81.4
—
0
5
(1616796) Gas panel - Central venous blood
42
283
1.50
1.71
4.1
4.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
20
111
1.81
1.69
1.3
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
208
1771
1.21
1.69
3.4
2.6
%
23.3
22.1
0.72
191
1509
(3025941) Bacteria identified in Stool by Culture
77
583
1.34
1.65
1.3
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
132
1074
1.25
1.65
7.8
8.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
79
601
1.33
1.64
1.4
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
140
1148
1.24
1.64
1.9
2.1
ug/g
92.7
151.9
2.54
96
891
(3020779) Urea [Moles/volume] in Serum or Plasma
144
1185
1.24
1.63
10.8
6.7
mmol/l
11.8
10.8
0.72
139
1127
(3024139) IgG subclass 3 [Mass/volume] in Serum
18
98
1.85
1.62
1.6
1.3
g/l
0.4
0.4
—
10
68
(3028192) IgG subclass 2 [Mass/volume] in Serum
18
98
1.85
1.62
1.6
1.3
g/l
2.7
2.8
—
10
69
(3027135) IgG subclass 1 [Mass/volume] in Serum
18
98
1.85
1.62
1.6
1.3
g/l
7.2
7.3
—
10
69
(3026470) Cobalt [Mass/volume] in Blood
17
91
1.88
1.61
2.1
2.0
ug/l
2.8
3.3
0.34
17
79
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
23
136
1.70
1.59
1.2
1.2
nmol/l
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
322
2862
1.16
1.59
1.4
1.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
20
3.01
1.58
1.0
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
66
492
1.36
1.58
3.4
2.6
u/ml
0.4
0.4
0.02
39
289
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
449
4091
1.15
1.57
3.0
3.2
ng/l
2419.1
1589.1
0.92
383
3540
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
79
606
1.32
1.56
1.3
1.2
iu/ml
63.9
147.8
1.92
17
229
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
57
2.12
1.55
1.0
1.1
—
—
—
0
0
(4034850)
22
359
0.61
1.55
7.7
10.9
—
—
—
0
0
(4062490)
18
100
1.81
1.53
1.6
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
44
2.28
1.53
1.9
2.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
42
0.00
1.52
0.0
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
28
177
1.59
1.52
1.9
2.3
mg/l
40.6
27.5
—
5
41
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
43
0.00
1.52
0.0
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
37
250
1.49
1.51
1.1
1.3
e6/l
10.6
44.3
0.76
26
196
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
37
250
1.49
1.51
1.1
1.3
e6/l
14.3
711.0
0.95
28
203
(40768441) Liver Pathology biopsy report
16
86
1.87
1.50
1.3
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
64
480
1.35
1.48
2.3
2.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
216
1870
1.18
1.47
3.3
2.5
g/l
2.2
2.3
0.92
199
1731
(1761482) Bacteria [#/volume] in Urine by Culture
24
378
0.63
1.47
3.7
5.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
12
59
2.04
1.43
1.5
1.6
—
11.7
—
0
5
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
281
2497
1.16
1.39
4.2
4.1
ng/l
212.3
342.1
0.95
239
2097
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
23
2.62
1.37
1.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
6
23
2.62
1.37
1.7
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
23
2.62
1.37
1.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
331
2980
1.15
1.36
3.4
3.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
143
1201
1.21
1.36
2.0
2.1
g/l
0.2
0.2
2.25
133
1114
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
13
68
1.92
1.33
1.2
1.2
u/l
52.7
18.9
0.67
13
59
(3045788) Cell count panel - Pleural fluid
24
152
1.59
1.32
1.8
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
15
83
1.82
1.31
1.5
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
154
1.57
1.26
1.2
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
87
699
1.26
1.26
2.7
2.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
31
211
1.48
1.26
1.4
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
14
77
1.83
1.25
3.1
2.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
76
601
1.28
1.25
1.2
1.2
u/ml
122.6
232.3
0.97
69
544
(3019309) Folate [Moles/volume] in Red Blood Cells
295
2651
1.14
1.25
1.8
1.8
nmol/l
1133.7
1176.5
0.28
181
1973
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
28
187
1.51
1.24
1.1
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
86
1061
0.80
1.24
3.8
3.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
180
1561
1.18
1.22
1.9
1.8
—
—
—
0
0
(4027681)
11
56
1.97
1.22
1.4
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
20
124
1.62
1.21
1.3
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
59
454
1.31
1.20
3.0
3.1
g/l
0.3
0.3
0.12
24
176
(3025130) Human papilloma virus identified in Specimen
13
71
1.84
1.19
1.2
1.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
34
239
1.43
1.19
1.5
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
35
248
1.42
1.17
1.4
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
23
149
1.55
1.17
1.8
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
13
72
1.81
1.15
3.2
3.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
23
150
1.54
1.15
2.8
2.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
104
864
1.22
1.14
3.6
3.0
g/l
10.7
10.9
0.09
96
783
(40760888) Immunoglobulin light chains.free panel - Serum
47
353
1.34
1.13
6.0
3.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
45
336
1.35
1.13
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
67
530
1.28
1.12
1.7
1.9
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
30
2.34
1.12
1.6
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
23
151
1.53
1.12
1.8
1.5
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
13
73
1.79
1.11
1.2
1.2
u/l
117.8
83.0
0.61
13
65
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
33
235
1.41
1.09
1.3
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
32
2.19
1.08
1.3
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
45
339
1.34
1.07
1.1
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
35
253
1.39
1.07
1.4
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
158
1373
1.17
1.07
1.4
1.3
titre
472.2
484.3
0.03
36
301
(3011985) Renin [Units/volume] in Plasma
21
137
1.54
1.06
1.5
1.3
mu/l
35.6
46.3
0.21
15
122
(3022948) Iron [Moles/volume] in Serum or Plasma
227
2030
1.14
1.04
3.2
2.5
umol/l
12.7
12.4
0.35
207
1873
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
22
2.28
1.03
1.2
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
44
333
1.33
1.03
1.1
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
425
3953
1.11
1.01
3.2
3.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
220
1969
1.14
1.00
2.0
1.5
g/l
2.6
2.6
0.06
126
1146
(3000012) Reticulocyte production index
12
68
1.77
1.00
1.1
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
36
265
1.37
1.00
1.2
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
16
99
1.62
1.00
2.3
1.9
e9/l
0.9
1.0
—
10
58
(3039443) Prostate specific Ag panel - Serum or Plasma
25
173
1.45
0.98
1.6
1.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
29
0.00
0.97
0.0
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
100
1.61
0.97
1.1
1.1
u/ml
0.3
1.6
—
7
38
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
17
108
1.58
0.96
1.9
2.0
mg/l
4.2
4.6
0.10
17
103
(3025468) Yersinia sp identified in Specimen by Organism specific culture
22
149
1.48
0.95
1.8
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
22
149
1.48
0.95
1.8
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
31
225
1.39
0.95
1.9
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
11
62
1.78
0.94
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
11
62
1.78
0.94
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
11
62
1.78
0.94
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
62
1.78
0.94
1.4
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
7
37
1.90
0.94
1.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
7
37
1.90
0.94
1.7
2.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
12
70
1.72
0.92
2.7
2.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
17
256
0.66
0.92
1.1
1.1
—
5.5
—
0
21
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
22
151
1.46
0.90
1.8
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
84
702
1.21
0.90
1.2
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
67
548
1.23
0.89
1.6
2.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
13
79
1.65
0.88
1.1
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
12
72
1.67
0.85
1.3
1.3
mmol/l
12.1
11.9
—
6
18
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
21
145
1.46
0.85
2.0
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
175
1563
1.14
0.84
1.9
1.8
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
13
80
1.63
0.84
1.0
1.2
nmol/l
3.9
5.4
—
5
15
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
41
318
1.30
0.84
1.6
1.6
iu/ml
0.1
19.8
—
10
61
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
31
1.94
0.84
1.2
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
31
1.94
0.84
1.0
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
57
699
0.81
0.84
2.9
3.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
105
1215
0.85
0.84
1.9
2.6
ug/l
7.3
6.7
0.15
89
1050
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
10
57
1.76
0.83
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
174
1555
1.14
0.83
5.4
8.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
23
163
1.42
0.82
1.9
1.7
g/l
0.8
0.9
0.15
14
126
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
402
3766
1.10
0.82
2.9
2.5
u/l
58.6
57.3
0.17
354
3459
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
73
1.65
0.81
1.4
1.6
u/l
28.8
8.6
—
6
37
(3004451) EKG impression Narrative
12
73
1.65
0.81
1.2
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
37
285
1.31
0.81
2.3
2.3
g/l
125.6
127.9
0.21
30
208
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
47
1.71
0.80
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
122
1.48
0.80
1.2
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
12
74
1.63
0.78
2.6
1.9
%
19.2
14.2
—
5
31
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
14
90
1.56
0.78
1.1
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
32
243
1.32
0.77
1.2
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
27
200
1.36
0.76
2.4
2.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
209
1.35
0.76
7.9
3.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
52
423
1.24
0.75
1.1
1.1
titre
—
147.9
—
0
9
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
11
67
1.65
0.75
5.3
6.4
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
12
75
1.61
0.75
2.8
1.9
%
70.4
72.2
0.10
12
70
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
238
2184
1.11
0.74
1.2
1.2
u/ml
1.3
1.6
0.19
68
550
(3008898) HLA-B27 [Presence]
19
266
0.71
0.74
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
19
133
1.43
0.73
1.1
1.2
u/ml
2.7
6.7
—
6
64
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
7
38
1.85
0.73
1.3
1.3
%
27.6
23.6
—
7
29
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
25
2.00
0.72
1.2
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
5
25
2.00
0.72
7.6
3.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
25
2.00
0.72
1.2
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
39
1.80
0.72
1.1
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
56
1.61
0.72
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
56
1.61
0.72
1.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
60
1.67
0.72
1.2
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
60
1.67
0.72
1.2
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
151
1.40
0.71
1.9
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
194
0.67
0.71
1.5
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
9
57
1.58
0.71
4.0
3.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
88
759
1.17
0.71
2.8
3.1
e9/l
4.0
4.1
0.16
52
559
(3025159) Blasts/100 leukocytes in Blood
104
910
1.15
0.70
4.5
4.2
%
0.0
0.4
0.61
29
250
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
21
152
1.39
0.69
1.1
1.1
g/l
1.5
1.6
1.00
21
135
(3008401) Mugwort IgE Ab [Units/volume] in Serum
13
85
1.53
0.69
1.1
1.0
u/ml
1.0
2.7
—
6
30
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
85
1.53
0.69
1.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
10
61
1.64
0.68
1.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
61
1.64
0.68
1.0
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
36
285
1.27
0.67
2.4
2.7
%
15.2
15.9
0.51
22
143
(3017704) Immunofixation for Urine
5
92
0.54
0.67
5.4
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
49
403
1.22
0.66
1.4
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
28
1.79
0.66
1.4
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
13
86
1.52
0.66
1.1
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
28
215
1.31
0.65
1.1
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
60
505
1.20
0.65
3.6
3.4
u/ml
1869.9
7974.4
0.54
51
435
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
142
1279
1.12
0.63
1.5
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
13
87
1.50
0.63
1.2
1.0
u/ml
3.3
2.6
—
7
34
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
35
280
1.26
0.61
5.1
5.0
mmol/l
2.0
2.7
0.47
24
198
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
50
1.60
0.61
1.3
1.0
—
—
—
0
0
(4306422)
16
113
1.42
0.61
1.3
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
8
51
1.57
0.60
1.5
1.2
mmol/l
5.6
6.4
—
8
51
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
8
52
1.54
0.59
1.0
1.2
%
—
65.7
—
0
7
(3022493) Free Hemoglobin [Mass/volume] in Plasma
8
52
1.54
0.59
16.6
1.9
mg/l
44.1
61.2
—
8
39
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
131
1.38
0.59
1.2
1.1
—
—
—
0
0
(3010421) pH of Blood
42
345
1.22
0.59
5.2
4.6
ph
7.4
7.4
0.30
35
276
(3011397) Hemoglobin [Presence] in Urine by Test strip
288
2701
1.08
0.58
3.6
3.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
53
1.51
0.58
1.9
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
53
1.51
0.58
1.9
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
185
0.70
0.58
2.8
2.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
253
0.75
0.58
1.3
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
55
466
1.19
0.57
1.3
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
54
1.48
0.57
1.9
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
34
274
1.25
0.57
1.7
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
184
1694
1.10
0.56
1.3
1.2
u/ml
14.1
14.0
0.00
51
604
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
36
1.67
0.56
1.7
2.0
ug/l
21.8
243.6
—
6
31
(3004616) Nuclear Ab [Presence] in Serum
20
150
1.34
0.56
1.5
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
10
65
1.54
0.55
1.1
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
104
930
1.13
0.54
4.1
4.0
%
0.7
0.6
0.07
26
230
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
60
1.50
0.54
1.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
99
1.42
0.54
1.1
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
39
1.54
0.53
1.2
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
66
1.52
0.52
1.1
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
68
778
0.87
0.52
1.1
1.2
—
—
—
0
0
(4211845)
9
63
1.43
0.52
4.0
3.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
63
1.43
0.52
3.3
3.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
414
4330
0.94
0.52
4.0
4.3
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
6
40
1.50
0.51
1.0
1.1
ng/l
—
70.2
—
0
10
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
64
1.41
0.51
1.2
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
48
407
1.19
0.51
1.3
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
78
688
1.14
0.51
3.0
1.8
g/l
1.2
1.6
0.86
73
621
(3021440) Promyelocytes/100 leukocytes in Blood
108
974
1.12
0.50
4.5
4.2
%
0.2
0.1
0.49
32
294
(3023368) Bacteria identified in Blood by Culture
383
3654
1.07
0.49
5.4
4.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
46
1.52
0.48
3.0
2.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
93
1.40
0.48
1.2
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
41
345
1.19
0.48
3.2
3.2
nmol/l
0.8
0.8
0.39
34
268
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
25
309
0.81
0.46
1.6
1.7
mg/l
2.3
2.7
0.19
19
240
(3005570) Glucose [Moles/volume] in Urine
17
129
1.32
0.46
1.9
2.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
58
506
1.15
0.45
1.5
1.9
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
77
1.43
0.45
1.2
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
77
1.43
0.45
1.2
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
68
768
0.88
0.45
1.6
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
50
1.40
0.45
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
23
183
1.26
0.45
1.9
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
51
587
0.86
0.44
1.9
1.9
ug/l
2.0
1.9
0.02
42
510
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
42
358
1.18
0.44
1.4
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
133
1224
1.10
0.44
2.4
3.0
ng/l
215.7
230.3
0.15
118
1130
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
41
349
1.18
0.43
3.1
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
127
0.71
0.43
1.8
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
104
1.35
0.43
2.0
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
31
1.62
0.43
1.6
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
56
1.43
0.42
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
173
0.75
0.42
1.5
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
79
709
1.12
0.42
7.1
10.2
—
—
—
0
0
(4198724)
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
2.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
38
324
1.18
0.40
2.4
1.7
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
18
0.00
0.40
0.0
1.1
—
1.8
—
0
18
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
13
97
1.34
0.39
1.2
1.1
—
63.6
—
0
5
(3027944) Amphetamines [Presence] in Urine
10
137
0.73
0.39
1.9
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
41
354
1.16
0.38
1.4
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
27
323
0.83
0.38
3.2
2.4
ug/min
96.8
71.5
0.26
21
191
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
36
1.39
0.38
1.2
1.2
ug/l
8.0
9.4
—
5
36
(3006245) CD3-CD19+ cells/100 cells in Blood
5
36
1.39
0.38
4.8
2.3
%
4.8
8.7
—
5
31
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
36
1.39
0.38
1.2
1.1
miu/ml
861.2
1709.3
—
5
36
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
67
1.35
0.38
1.9
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
13
98
1.33
0.37
1.2
1.1
—
50.5
—
0
10
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
72
1.39
0.37
1.0
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
72
1.39
0.37
1.0
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
70
1.29
0.36
1.6
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
70
1.29
0.36
1.6
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
70
1.29
0.36
2.0
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
135
0.74
0.36
1.0
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
71
1.27
0.36
1.8
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
71
1.27
0.36
1.8
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
71
1.27
0.36
1.8
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
71
1.27
0.36
1.8
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
77
0.65
0.35
4.8
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
78
0.64
0.35
1.6
1.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
99
1.32
0.35
1.2
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
17
135
1.26
0.35
1.2
1.2
—
79.5
—
0
5
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
501
4864
1.05
0.35
3.5
4.1
ng/l
36.2
50.4
1.06
369
3694
(44790048)
11
145
0.76
0.34
1.6
1.5
—
—
—
0
0
(44790049)
11
145
0.76
0.34
1.6
1.5
—
—
—
0
0
(44790047)
11
145
0.76
0.34
1.6
1.5
—
—
—
0
0
(44806118)
11
145
0.76
0.34
1.6
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
11
82
1.34
0.34
2.2
2.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
182
1.21
0.33
1.8
1.2
u/ml
267.4
300.3
0.22
12
96
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
88
0.68
0.33
2.2
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
220
0.82
0.32
1.8
1.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
17
137
1.24
0.32
1.0
1.3
mosm/kgh2o
274.9
277.5
0.22
12
97
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
14
110
1.28
0.31
1.2
2.1
u/field
3.0
1.9
—
6
43
(4094501)
34
295
1.16
0.31
1.1
1.1
—
—
—
0
0
(4146454)
18
147
1.23
0.30
2.3
2.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
29
249
1.17
0.30
1.1
1.3
mmol/l
66.9
62.8
0.13
24
200
(21494755) Public health laboratory ask at order entry panel
46
514
0.89
0.29
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
56
1.25
0.29
1.1
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
56
1.25
0.29
1.1
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
289
2784
1.05
0.28
1.7
1.8
pmol/l
45370797.7
14659421.1
0.30
216
2258
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
121
1.24
0.28
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
26
223
1.17
0.28
1.3
1.4
—
—
—
0
0
(4268621)
12
94
1.28
0.28
2.0
2.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
146
1542
0.94
0.27
6.1
7.4
mmol/l
0.8
1.1
0.45
122
1196
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
5
71
0.70
0.26
5.2
2.9
—
37.4
—
0
23
(3020191) Ethanol [Moles/volume] in Serum or Plasma
5
71
0.70
0.26
1.4
1.4
promille
2.3
1.0
—
5
56
(3042111) Morphology [Interpretation] in Bone marrow Narrative
28
244
1.15
0.26
1.2
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
149
0.80
0.25
1.8
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
72
1.25
0.25
2.4
2.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
138
0.80
0.25
1.1
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
138
0.80
0.25
1.7
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
138
0.80
0.25
1.7
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
15
123
1.22
0.25
1.1
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
88
821
1.08
0.25
3.5
3.9
mmol/l
1.4
2.0
1.25
61
627
(3000570) Elastase.pancreatic [Mass/mass] in Stool
41
368
1.12
0.25
1.3
1.4
ug/g
299.8
276.2
0.35
21
227
(3050129) First trimester maternal screen panel - Serum or Plasma
9
75
1.20
0.25
1.8
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
191
1829
1.05
0.25
37.4
29.4
inr
1.2
1.4
0.90
18
246
(3014007) Fractional oxyhemoglobin in Arterial blood
88
822
1.08
0.24
8.1
9.3
%
94.5
93.9
0.57
88
815
(4010399)
96
900
1.07
0.24
1.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
137
0.80
0.24
1.7
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
78
1.28
0.24
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
78
1.28
0.24
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
78
1.28
0.24
1.0
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
110
1038
1.07
0.23
4.5
4.1
%
0.8
0.9
0.16
35
325
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
57
524
1.09
0.23
3.9
4.2
mmol/l
25.2
25.0
0.19
50
491
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
24
209
1.15
0.23
1.7
2.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
91
0.77
0.22
1.0
1.0
—
—
—
0
0
(4281824)
15
125
1.20
0.22
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
79
1.27
0.22
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
79
1.27
0.22
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
79
1.27
0.22
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
48
524
0.91
0.22
1.6
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
178
0.84
0.22
1.9
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
91
856
1.07
0.22
3.5
3.9
ph
7.4
7.4
0.21
16
112
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
14
167
0.84
0.21
3.1
2.2
u/ml
5.3
29.8
0.54
14
162
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
135
1.19
0.21
1.7
1.7
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001729) Color of Synovial fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.3
—
22.8
—
0
5
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
104
0.77
0.21
1.9
1.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
43
1.16
0.21
1.2
2.3
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
43
1.16
0.21
1.0
2.6
—
49601.2
—
0
9
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
89
1.24
0.21
1.1
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
22
192
1.15
0.20
1.5
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
19
164
1.16
0.20
1.9
1.2
—
—
—
0
0
(44806071)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
108
1.21
0.20
1.2
1.1
—
—
—
0
0
(4015189)
6
49
1.23
0.20
1.3
2.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
154
0.84
0.19
2.8
4.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
119
1246
0.95
0.19
3.7
3.5
mmol/l
2.0
2.0
0.01
105
989
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
53
1.13
0.18
1.2
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
33
299
1.11
0.18
1.9
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
20
175
1.14
0.18
2.0
1.4
u/ml
103.2
139.4
—
5
27
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
58
1.21
0.18
1.1
1.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
88
834
1.06
0.18
8.1
9.1
%
1.1
1.3
2.31
88
827
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
12
100
1.20
0.18
5.4
4.9
u/ml
14.2
35.0
—
5
27
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
82
1.22
0.17
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
63
1.11
0.17
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
63
1.11
0.17
1.1
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
67
631
1.07
0.17
3.7
3.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
28
253
1.11
0.17
1.8
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
120
1.17
0.16
1.0
1.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
87
828
1.05
0.16
8.0
9.2
%
0.6
0.7
0.89
87
821
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
92
1.20
0.16
2.2
2.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
102
1066
0.95
0.16
1.7
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
72
1.11
0.16
1.0
16.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
138
1330
1.04
0.16
1.5
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
73
1.10
0.15
1.8
2.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
29
264
1.10
0.15
2.7
3.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
91
869
1.05
0.15
3.5
3.9
kpa
5.2
5.2
0.08
85
809
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
42
450
0.93
0.14
1.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
202
0.89
0.14
1.1
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
34
314
1.08
0.14
1.8
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
16
141
1.14
0.14
1.1
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
33
306
1.08
0.13
1.3
1.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
24
219
1.10
0.12
1.6
1.9
mmol/l
1.4
1.7
1.57
24
213
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
97
934
1.04
0.12
1.6
1.6
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
15
133
1.13
0.12
1.0
1.1
—
16.6
—
0
7
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
21
191
1.10
0.11
1.2
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
95
1.16
0.11
1.1
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
14
157
0.89
0.11
1.6
1.5
%
43.4
63.0
—
7
106
(3023419) Bacteria identified in Sputum by Culture
17
188
0.90
0.11
2.4
2.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
16
177
0.90
0.10
1.3
1.3
miu/ml
171.8
234.7
—
5
70
(3002523) Influenza virus A Ag [Presence] in Specimen
11
96
1.15
0.10
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
14
125
1.12
0.10
1.8
1.8
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
45
1.11
0.09
1.2
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
46
1.09
0.09
1.0
2.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
317
3127
1.02
0.09
4.3
4.3
estimate
0.0
0.0
0.50
132
1047
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
52
498
1.05
0.09
1.6
1.7
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
6
55
1.09
0.09
1.7
1.4
%
65.7
59.6
—
6
42
(3022621) pH of Urine by Test strip
79
815
0.97
0.08
2.7
3.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
127
1.10
0.08
1.1
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
27
286
0.94
0.07
4.4
3.8
mg/l
32.8
27.5
0.23
15
179
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
157
1.08
0.07
1.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
86
1.05
0.07
1.6
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
35
334
1.05
0.06
1.9
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
90
0.89
0.06
1.3
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
14
128
1.09
0.06
2.0
2.3
—
—
—
0
0
(4024509)
11
121
0.91
0.06
1.3
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
47
454
1.04
0.06
1.6
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
92
939
0.98
0.05
2.8
3.0
ml/min/173m2
57.6
60.8
0.37
46
394
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
23
242
0.95
0.05
1.6
1.5
nmol/l
0.7
0.9
0.47
18
195
(1617658) Protocol used for examination of sentinel lymph nodes
10
91
1.10
0.04
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
21
201
1.05
0.03
2.1
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
26
251
1.04
0.02
1.5
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
31
301
1.03
0.02
1.5
1.2
—
746.3
—
0
8
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
168
0.95
0.02
1.4
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
46
452
1.02
0.01
1.4
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
163
1.04
0.01
1.0
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
11
114
0.96
0.00
2.0
1.3
%
51.0
30.5
—
6
74
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
122
0.98
0.00
1.3
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
142
0.99
0.00
2.3
2.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
17
169
1.01
0.00
1.5
1.9
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
107
1.03
0.00
2.5
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
30
295
1.02
0.00
1.7
2.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
115
1.04
0.00
1.7
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
115
1.04
0.00
1.7
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
115
1.04
0.00
1.7
1.6
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
8
0.00
0.00
0.0
6.6
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
82
0.98
0.00
1.5
1.5
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
78
0.90
0.00
4.3
4.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
58
0.86
0.00
1.0
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
52
0.96
0.00
1.0
1.5
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
5
0.00
0.00
0.0
2.4
—
146.0
—
0
5
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
20.8
—
264.4
—
0
5
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44813793)
6
67
0.90
0.00
1.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
9
0.00
0.00
0.0
2.0
—
1.8
—
0
9
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
420.1
—
0
7
(3006653) Thiamine [Moles/volume] in Blood
7
69
1.01
0.00
1.1
1.3
nmol/l
111.6
141.4
—
7
69
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
0.1
—
0
6
(3029396) Erythrocyte agglutination [Presence] in Blood
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_MELANOMA – Melanoma in situ
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).